(NP (NP Prostaglandin/NN E2/NN induction/NN) (PP of/IN (NP (NP binding/NN activity/NN) (PP to/TO (NP (NP-COOD (NP CRE/NN) and/CC (NP AP-2/NN)) elements/NNS)))) (PP in/IN (NP human/JJ T/NN lymphocytes/NNS)) ./.)
(S (NP-SBJ (NP Prostaglandins/NNP) (PP of/IN (NP the/DT E/NN series/NNS))) (VP are/VBP (NP-PRD (NP immunomodulatory/JJ agents/NNS) (SBAR (WHNP-66 which/WDT) (S (NP-SBJ *T*-66/-NONE-) (VP exert/VBP (NP (ADJP-COOD (ADJP inhibitory/JJ) (CONJP as/RB well/RB as/IN) (ADJP stimulatory/JJ)) effects/NNS) (PP on/IN (NP (NP a/DT variety/NN) (PP of/IN (NP immune/JJ responses/NNS))))))))) ./.)
(S (SBAR Since/IN (S (NP-SBJ it/PRP) (VP is/VBZ (VP known/VBN (SBAR that/IN (S (NP-SBJ-67 PGE2/NN) (VP is/VBZ (ADJP-PRD able/JJ (S (NP-SBJ *-67/-NONE-) (VP to/TO (VP increase/VB (NP cAMP/NN levels/NNS)))))))))))) ,/, (NP-SBJ we/PRP) (VP investigated/VBD (SBAR whether/IN (S (NP-SBJ it/PRP) (VP can/MD (VP affect/VB (NP gene/NN expression/NN) (PP through/IN (NP (NP the/DT activation/NN) (PP of/IN (NP (NP the/DT transcription/NN factors/NNS) (SBAR (WHNP-68 which/WDT) (S (NP-SBJ *T*-68/-NONE-) (VP bind/VBP (NP (NP enhancer/NN elements/NNS) (PP in/IN (NP (NP the/DT promoter/NN regions/NNS) (PP of/IN (NP cAMP-regulated/JJ genes/NNS))))))))))))))))) ./.)
(S (S (NP-SBJ *-69/-NONE-) (VP Using/VBG (NP electrophoretic/JJ mobility/NN shift/NN assay/NN))) ,/, (NP-SBJ-69 we/PRP) (VP demonstrated/VBD (SBAR that/IN (S (NP-SBJ (NP a/DT short/JJ treatment/NN) (PP of/IN (NP human/JJ T/NN lymphocytes/NNS)) (PP with/IN (NP PGE2/NN))) (VP induces/VBZ (NP (NP specific/JJ binding/NN activity/NN) (PP to/TO (NP (NP-COOD (NP CRE/NN) and/CC (NP-COOD (NP AP-2/NN) ,/, (NP but/CC not/RB) (NP AP-1/NN) ,/,)) DNA/NN elements/NNS))))))) ./.)
(S (SBAR Since/IN (S (NP-SBJ (NP the/DT okadaic/JJ acid/NN) ,/, (NP a/DT potent/JJ protein/NN phosphatase/NN inhibitor/NN) ,/,) (VP prolongs/VBZ (NP (NP the/DT induction/NN) (PP of/IN (NP the/DT binding/NN activity/NN)))))) ,/, (NP-SBJ-70 phosphorylation/NN events/NNS) (VP are/VBP (ADJP-PRD likely/JJ (S (NP-SBJ *-70/-NONE-) (VP to/TO (VP occur/VB))))) ./.)
(S (NP-SBJ-71 This/DT activity/NN) (VP seems/VBZ (S (NP-SBJ *-71/-NONE-) (VP to/TO (VP be/VB (PP-PRD due/JJ to/TO (NP increased/VBN cAMP/NN levels/NNS)) (SBAR because/IN (S (NP-SBJ-COOD (NP forskolin/NN) and/CC (NP IBMX/NN)) (VP mimic/VBP (NP (NP the/DT effects/NNS) (PP of/IN (NP PGE2/NN)))))))))) ./.)
(S (ADVP More/RBR interestingly/RB) ,/, (NP-SBJ (NP transfection/NN experiments/NNS) (PP with/IN (NP CRE-CAT/NN plasmide/NN))) (VP show/VBP (SBAR that/IN (S (NP-SBJ PGE2/NN) (VP activates/VBZ (NP (NP the/DT transcription/NN) (PP of/IN (NP a/DT CRE-containing/NN promoter/NN))))))) ./.)
(S (NP-SBJ These/DT data/NNS) (VP support/VBP (NP (NP the/DT positive/JJ role/NN) (PP for/IN (NP PGE2/NN)) (PP on/IN (NP some/DT immune/JJ functions/NNS)))) ./.)
